Atara Biotherapeutics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ATRA research report →
Companywww.atarabio.com
Atara Biotherapeutics, Inc. , an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma.
- CEO
- Anhco Nguyen
- IPO
- 2014
- Employees
- 153
- HQ
- South San Francisco, CA, US
Price Chart
Valuation
- Market Cap
- $85.15M
- P/E
- -14.06
- P/S
- 3.68
- P/B
- -3.57
- EV/EBITDA
- -15.51
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 96.12%
- Op Margin
- -27.27%
- Net Margin
- -40.91%
- ROE
- 25.68%
- ROIC
- -43.96%
Growth & Income
- Revenue
- $120.77M · -6.33%
- Net Income
- $32.69M · 138.28%
- EPS
- $2.61 · 122.87%
- Op Income
- $35.86M
- FCF YoY
- 26.13%
Performance & Tape
- 52W High
- $19.14
- 52W Low
- $3.92
- 50D MA
- $5.95
- 200D MA
- $10.17
- Beta
- -0.29
- Avg Volume
- 1.57M
Get TickerSpark's AI analysis on ATRA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 18, 26 | Nguyen AnhCo | sell | 5,241 |
| May 18, 26 | Grant-Huerta Yanina | sell | 2,414 |
| May 7, 26 | Panacea Innovation Ltd | sell | 313,446 |
| May 7, 26 | EcoR1 Capital, LLC | buy | 507,407 |
| May 7, 26 | EcoR1 Capital, LLC | other | 0 |
| Mar 17, 26 | Panacea Innovation Ltd | other | 259,163 |
| Mar 17, 26 | Panacea Innovation Ltd | other | 5 |
| Mar 17, 26 | Panacea Innovation Ltd | other | 259,163 |
| Mar 9, 26 | Nguyen AnhCo | other | 81,100 |
| Mar 9, 26 | Grant-Huerta Yanina | other | 20,300 |
Our ATRA Coverage
We haven't published any research on ATRA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ATRA Report →